NFEC [NF Energyving] 8-K: (Original Filing)
[]
NFEC [NF Energyvingrp] 8-K: (Original Filing)
[Item 8.01. Other Events The Board of Directors of NF Energyvingrporation (thempany) has determined to hold its Annual Meeting of Stockholders on December 20, 2012. The recordte for stockholders eligible to vote at the meeting will be duly noticed in accordance with state law, thempanys by-laws and SEC requirements. The proxy materials willlude the Annual]
NFEC [NF Energyvingrp] 8-K: Item 8.01. Other Events The Board of Directors
[Item 8.01. Other Events The Board of Directors of NF Energyvingrporation (thempany) has determined to hold its Annual Meeting of Stockholders on December 20, 2012. The recordte for stockholders eligible to vote at the meeting will be duly noticed in accordance with state law, thempanys by-laws and SEC requirements. The proxy materials willlude the Annual]
KGJI [KINGOLD JEWELRY] 8-K: (Original Filing)
[LLP Reed Smith 599 Lexington Avenue reedsmith.com October 4, 2012 Kingold Jewelry, Inc. Ladies and Gentlemen: Company Shares Common Stock Loan Agreement EFH Prospectus Supplement Base Prospectus Registration Statement Prospectus Securities Act Resolutions NEW YORK ¨ LONDON ¨ HONG KONG ¨ CHICAGO ¨ ¨ BEIJING ¨ PARIS ¨ LOS ANGELES ¨ SAN FRANCISCO ¨ PHILADELPHIA ¨ SHANGHAI ¨ PITTSBURGH MUNICH] [STOCK LOAN AND REPURCHASE AGREEMENT Borrower Lender This Stock Loan and Repurchase Agreement is between Kingold Jewelry, Inc. having an address of 15 Huangpu Science and Technology Park, Jiang'an District, Wuhan, Hubei Province, 430023, China, P.R. (the “ WITNESSETH WHEREAS, WHEREAS, NOW THEREFORE, Article 1 DEFINITIONS Defined Terms 1.1 “Agreement “Change in Collateral” Approved Exchange “Closing Statement” “Common Stock” “Event] []
KGJI [KINGOLD JEWELRY] 8-K: LLP Reed Smith 599 Lexington Avenue reedsmith.com October
[LLP Reed Smith 599 Lexington Avenue reedsmith.com October 4, 2012 Kingold Jewelry, Inc. Ladies and Gentlemen: Company Shares Common Stock Loan Agreement EFH Prospectus Supplement Base Prospectus Registration Statement Prospectus Securities Act Resolutions NEW YORK ¨ LONDON ¨ HONG KONG ¨ CHICAGO ¨ ¨ BEIJING ¨ PARIS ¨ LOS ANGELES ¨ SAN FRANCISCO ¨ PHILADELPHIA ¨ SHANGHAI ¨ PITTSBURGH MUNICH] [STOCK LOAN AND REPURCHASE AGREEMENT Borrower Lender This Stock Loan and Repurchase Agreement is between Kingold Jewelry, Inc. having an address of 15 Huangpu Science and Technology Park, Jiang'an District, Wuhan, Hubei Province, 430023, China, P.R. (the “ WITNESSETH WHEREAS, WHEREAS, NOW THEREFORE, Article 1 DEFINITIONS Defined Terms 1.1 “Agreement “Change in Collateral” Approved Exchange “Closing Statement” “Common Stock” “Event] []
THTI [THT Heat Transfer Technology] 8-K: (Original Filing)
[THT Heat Transfer Technology Announces Departure of Chief Financial Officer SIPING, CHINA Mr. Xu has held various positions in the Company’s subsidiaries Siping City Juyuan Hanyang Plate Heat Exchanger Co. Ltd. (“Siping Juyuan”) and Beijing Juyuan Hanyang Heat Exchange Equipment Co., Ltd. (“Beijing Juyuan”) since 2000, including Financial Director of Beijing Juyuan. From 1993 to 1999, Mr. Xu worked as] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): October 4, 2012 (September 29, 2012) THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 001-34812 20-5463509 (State or other jurisdiction of incorporation (IRS Employer Identification No.) or organization) THT Industrial Park No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 People's Republic of China 86-434-3265241 (Former name or former address,]
THTI [THT Heat Transfer Technology] 8-K: THT Heat Transfer Technology Announces Departure of Chief
[THT Heat Transfer Technology Announces Departure of Chief Financial Officer SIPING, CHINA Mr. Xu has held various positions in the Company’s subsidiaries Siping City Juyuan Hanyang Plate Heat Exchanger Co. Ltd. (“Siping Juyuan”) and Beijing Juyuan Hanyang Heat Exchange Equipment Co., Ltd. (“Beijing Juyuan”) since 2000, including Financial Director of Beijing Juyuan. From 1993 to 1999, Mr. Xu worked as] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): October 4, 2012 (September 29, 2012) THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 001-34812 20-5463509 (State or other jurisdiction of incorporation (IRS Employer Identification No.) or organization) THT Industrial Park No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 People's Republic of China 86-434-3265241 (Former name or former address,]
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[TPI Reports Fiscal Year 2012 Financial Results CHENGDU, China, September 28, 2012 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2012. Fiscal Year 2012 Ended June 30, 2012 Financial Highlights: ● FY2012 revenue delivered] [Tianyin Pharmaceutical Co., Inc. Fiscal 2012 Earnings Call September 28, 2012 Operator: I would now like to turn the conference over to our host, Dr. James Tong, Chief Financial Officer. Please go ahead, sir. Dr. James Tong: Fiscal year 2012 financial highlights. Revenue delivered $69.6 million, compared with $95.2 million in fiscal year 2011. Operating income delivered $8.5 million, compared] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT September 28, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Fiscal Year 2012 Financial Results CHENGDU,
[TPI Reports Fiscal Year 2012 Financial Results CHENGDU, China, September 28, 2012 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2012. Fiscal Year 2012 Ended June 30, 2012 Financial Highlights: ● FY2012 revenue delivered] [Tianyin Pharmaceutical Co., Inc. Fiscal 2012 Earnings Call September 28, 2012 Operator: I would now like to turn the conference over to our host, Dr. James Tong, Chief Financial Officer. Please go ahead, sir. Dr. James Tong: Fiscal year 2012 financial highlights. Revenue delivered $69.6 million, compared with $95.2 million in fiscal year 2011. Operating income delivered $8.5 million, compared] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT September 28, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
